Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
about
Hypercholesterolemia, low density lipoprotein receptor and proprotein convertase subtilisin/kexin-type 9Emerging role of mast cells and macrophages in cardiovascular and metabolic diseasesConstitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct targetCD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infectionEffects of 5-aminolevulinic acid-mediated sonodynamic therapy on macrophagesMicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation.ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesisImpact of hydrophobic chain composition on amphiphilic macromolecule antiatherogenic bioactivityTranscriptome analysis of genes regulated by cholesterol loading in two strains of mouse macrophages associates lysosome pathway and ER stress response with atherosclerosis susceptibilityUncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.D4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathwayEthanol extract of propolis protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting CD36 expression and endoplasmic reticulum stress-C/EBP homologous protein pathwayHigh intrinsic aerobic capacity and pomegranate juice are protective against macrophage atherogenecity: studies in high- vs. low-capacity runner (HCR vs. LCR) ratsTARGETING OF MACROPHAGE FOAM CELLS IN ATHEROSCLEROTIC PLAQUE USING OLIGONUCLEOTIDE-FUNCTIONALIZED NANOPARTICLESSpecific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL.Effects of acute and chronic low density lipoprotein exposure on neutrophil function.Pomegranate for your cardiovascular healthInflammation at the molecular interface of atherogenesis: an anthropological journeyApoptosis of THP-1 macrophages induced by protoporphyrin IX-mediated sonodynamic therapy.Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis.MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient MiceEndoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression.Inflammation in atherosclerosis: a cause or a result of vascular disorders?Molecular and cellular mechanisms of macrophage survival in atherosclerosis.Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway.MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7.Selective oxidative stress and cholesterol metabolism in lipid-metabolizing cell classes: Distinct regulatory roles for pro-oxidants and antioxidants.Cloning and expression of an anti-LDL(-) single-chain variable fragment, and its inhibitory effect on experimental atherosclerosis.Oxidized high density lipoprotein induces macrophage apoptosis via toll-like receptor 4-dependent CHOP pathway.M2 macrophages exhibit higher sensitivity to oxLDL-induced lipotoxicity than other monocyte/macrophage subtypesEffect of reconstituted discoidal high-density lipoproteins on lipid mobilization in RAW 264.7 and CHOK1 cells.Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice.Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1.Apolipoprotein E-Deficient Lipoproteins Induce Foam Cell Formation by Activation of PERK-EIF-2α Signaling Cascade.A systems biology and proteomics-based approach identifies SRC and VEGFA as biomarkers in risk factor mediated coronary heart disease.A time course study on prothrombotic parameters and their modulation by anti-platelet drugs in hyperlipidemic hamsters.Insulin increases macrophage triglyceride accumulation under diabetic conditions through the down regulation of hormone sensitive lipase and adipose triglyceride lipase.
P2860
Q26786549-EAC9021C-AFCD-46A4-8ADC-FDB26546391CQ26825467-427557F8-7F89-4815-841D-82550C823B6EQ28588828-30927192-29FD-4B50-B7F2-A8995FBFA1FEQ28910367-7C1E1494-F09B-4425-98D7-41B4DDAB54CFQ30458115-24ED13A6-FA98-4066-AC74-9FD7855C2760Q33675241-1035AF8F-0FA0-47DB-8E0C-66399CD9447AQ34043933-A02BB367-C812-4EC2-84C0-47B1E049E1EBQ34112680-3E54904F-5968-4F08-BDEE-C37D1C28465DQ34123761-BECCCD68-DD72-4FB0-929C-44869E1763F0Q34149692-C3632739-4173-4939-87E6-7C42E97C2079Q34738282-DB882DB5-5DF1-4260-BC9F-49146E0F7AF8Q35097086-8DEB9C15-DEC5-4736-AC57-A8768D041BA7Q35217041-DCDCD874-4098-4D78-BE16-605DD0A66CA1Q35689909-7C3990BB-E923-4932-B3C0-8F0CC98DE022Q36083392-50B431B7-82D2-4947-8663-9A41FF0303DCQ36359313-61B73620-562A-4664-A9BA-B93A4AE1185AQ36462111-E9EDDE5C-5659-43BE-BD55-F31A4CBCA521Q36612117-6D5FDDB5-3F55-4D56-86DB-D66E099B6403Q36919245-A25C6910-E3A4-4AC0-A0CC-097AE903F09CQ36943039-32E720BA-2C9B-48ED-A532-55E1EC9D40EDQ36957954-2658C79E-0A87-4512-B58A-E9AF2BD11D47Q37075460-DA381067-DC9C-493B-AF44-71A4E1FB0845Q37254485-DAA4EBF8-564F-4D2B-B173-57E082646A37Q37465715-BE60C4B2-366A-4986-9747-80005D0D72CBQ37583467-BAF04462-94E3-4ACE-8002-D9FDA5983A71Q37986175-9165EC09-CE81-4CC5-ADCE-60B24C3A3B76Q38042543-E7291477-479A-4F37-B8B3-A97A8CE90EB7Q38323245-41C75E7E-F59A-47DD-A891-2DCBA441DC57Q38324718-FF7C42B1-C661-4614-A9A2-45814C5C3961Q38847658-651838DD-441D-49A6-B350-9E699F7F3E38Q39113883-98477219-ECD5-4F74-8A7F-0A3250E48CD1Q39147502-A5DBFDD6-8823-4021-B5CE-6049DC6FFFC3Q39432343-2B2B8629-E1BF-49D0-A91E-DCD8A61D1EE4Q39441003-A2B5115D-AB17-4412-A730-94AD7860045EQ41673298-907ABCB8-5C77-416E-BF72-C2BD4AECD4B0Q41788213-C13D1AB4-B8FA-403E-99D9-65C91F95FFA7Q42725728-97E514F4-8BC3-4F6D-9140-2EB1237BFE93Q50630756-FFB6445E-1D5B-41AD-9B72-E5F1FA1D8ADFQ51769781-344DA820-98D3-430E-A9A8-7AE7D09B388FQ54386404-A2FACB3A-6782-4CCE-94BD-5547D4E1E5D3
P2860
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
@en
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
@nl
type
label
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
@en
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
@nl
prefLabel
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
@en
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
@nl
P2860
P356
P1476
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis
@en
P2093
P2860
P304
P356
10.1002/MED.20118
P50
P577
2008-07-01T00:00:00Z